Sidley Austin represented Zai Lab Limited on the offering. Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) (“Zai Lab”) announced its US$230 million equity offering of American...
You must be a Standard 1 Year member to access this content.
Ropes & Gray represented Zai Lab Limited in the offering, while Simpson Thacher & Bartlett represented the underwriters. Zai Lab Limited (“Zai Lab” or the “Company”)...
You must be a Standard 1 Year member to access this content.
Cooley advised Zai Lab on the deal. Zai Lab, a research-based commercial-stage biopharmaceutical company, announced its strategic partnership and exclusive worldwide license agreement with MediLink Therapeutics, as...
You must be a Standard 1 Year member to access this content.
Goodwin Procter LLP advised Zai Lab Limited on the deal. Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) announced its broad strategic collaboration and license agreement with MacroGenics...
You must be a Standard 1 Year member to access this content.
Davis Polk advised Zai Lab Limited in the deal, while Simpson Thacher represented the underwriters. Zai Lab Limited executed its offering of 5,492,400 American depositary shares,...
You must be a Standard 1 Year member to access this content.
